miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1

Bioscience Reports

Volumn 35, Issue 4, 2015, Pages

  Liu, Qinying ^a   Xu, Yangmei ^a   Wei, Shenghong ^a   Gao, Wei ^a   Chen, Li ^b   Zhou, Tong ^b   Wang, Zhen ^a   Ying, Mingang ^a   Zheng, Qiuhong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUZHOU UNIVERSITY   (China)

Author keywords

Cancer stem cell; Hepatocellular carcinoma; microRNA 148b; Neuropilin 1; Side population cell

Indexed keywords

MICRORNA; MICRORNA 148B; NEUROPILIN 1; UNCLASSIFIED DRUG; MIRN148 MICRORNA, HUMAN; RNA; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL MIGRATION; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER METASTASIS; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; SIDE POPULATION CELL; TUMOR INVASION; TUMOR XENOGRAFT; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM PROTEINS; NEUROPILIN-1; RNA, NEOPLASM;

EID: 84938821812     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20150084     Document Type: Article

References (37)

1. Pang, R.W. and Poon, R.T. (2012) Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma. Curr. Cancer Drug Targets 12, 1081-1094 PubMed
2. Leal, J.A. and Lleonart, M.E. (2012) MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives. Cancer Lett. 338, 174-183 CrossRef PubMed
3. Qi, W., Liang, W., Jiang, H. and Miuyee Waye, M. (2014) The function of miRNA in hepatic cancer stem cell. Biomed. Res. Int. 2013, 358902
4. Zimmerman, A.L. and Wu, S. (2010) MicroRNAs, cancer and cancer stem cells. Cancer Lett. 300, 10-19 CrossRef PubMed
5. Chiba, T., Kita, K., Zheng, Y.W., Yokosuka, O., Saisho, H., Iwama, A., Nakauchi, H. and Taniguchi, H. (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44, 240-251 CrossRef PubMed
6. Ji, J., Yamashita, T. and Wang, X.W. (2011) Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. Cell Biosci. 1, 4 CrossRef PubMed
7. Ji, J., Yamashita, T., Budhu, A., Forgues, M., Jia, H.L., Li, C., Deng, C., Wauthier, E., Reid, L.M., Ye, Q.H. et al. (2009) Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50, 472-480 CrossRef PubMed
8. Zhou, L., Yang, Z.X., Song, W.J., Li, Q.J., Yang, F., Wang, D.S., Zhang, N. and Dou, K.F. (2013) MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma. Int. J. Oncol. 43, 661-669 PubMed
9. Chai, S., Tong, M., Ng, K.Y., Kwan, P.S., Chan, Y.P., Fung, T.M., Lee, T.K., Wong, N., Xie, D., Yuan, Y.F. et al. (2014) Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133. Oncotarget 5, 5725-5735 PubMed
10. Jia, Y., Liu, H., Zhuang, Q., Xu, S., Yang, Z., Li, J., Lou, J. and Zhang, W. (2012) Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Oncol. Rep. 27, 1865-1872 PubMed
11. Zhang, J., Luo, N., Luo, Y., Peng, Z., Zhang, T. and Li, S. (2011) microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int. J. Oncol. 40, 747-756 PubMed
12. Tang, J., Tao, Z.H., Wen, D., Wan, J.L., Liu, D.L., Zhang, S., Cui, J.F., Sun, H.C., Wang, L., Zhou, J. et al. (2014) MiR-612 suppresses the stemness of liver cancer via Wnt/beta-catenin signaling. Biochem. Biophys. Res. Commun. 447, 210-215 CrossRef PubMed
13. Liu, J., Ruan, B., You, N., Huang, Q., Liu, W., Dang, Z., Xu, W., Zhou, T., Ji, R., Cao, Y. et al. (2013) Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the beta-catenin pathway in hepatic oval cells. PLoS One 8, e79409 CrossRef PubMed
14. Oishi, N., Kumar, M.R., Roessler, S., Ji, J., Forgues, M., Budhu, A., Zhao, X., Andersen, J.B., Ye, Q.H., Jia, H.L. et al. (2012) Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 56, 1792-1803 CrossRef PubMed
15. Xu, Y., Xie, Y., Wang, X., Chen, X., Liu, Q., Ying, M. and Zheng, Q. (2013) Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs. Oncol. Rep. 30, 2056-2062 PubMed
16. Liu, W.H., Tao, K.S., You, N., Liu, Z.C., Zhang, H.T. and Dou, K.F. (2011) Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells. PLoS One 6, e23311 CrossRef PubMed
17. Song, Y., Xu, Y., Wang, Z., Chen, Y., Yue, Z., Gao, P., Xing, C. and Xu, H. (2011) MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int. J. Cancer 131, 1042-1051 CrossRef PubMed
18. Song, Y.X., Yue, Z.Y., Wang, Z.N., Xu, Y.Y., Luo, Y., Xu, H.M., Zhang, X., Jiang, L., Xing, C.Z. and Zhang, Y. (2011) MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol. Cancer 10, 1 CrossRef PubMed
19. Cimino, D., De Pitta, C., Orso, F., Zampini, M., Casara, S., Penna, E., Quaglino, E., Forni, M., Damasco, C., Pinatel, E. et al. (2012) miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J. 27, 1223-1235 CrossRef PubMed
20. Wu, Y., Liu, G.L., Liu, S.H., Wang, C.X., Xu, Y.L., Ying, Y. and Mao, P. (2012) MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis. J. Radiat. Res. 53, 516-525 CrossRef PubMed
21. Zhao, G., Zhang, J.G., Liu, Y., Qin, Q., Wang, B., Tian, K., Liu, L., Li, X., Niu, Y., Deng, S.C. et al. (2012) miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKalpha1. Mol. Cancer Ther. 12, 83-93 CrossRef PubMed
22. Liu, G.L., Liu, X., Lv, X.B., Wang, X.P., Fang, X.S. and Sang, Y. (2014) miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA). Int. J. Clin. Exp. Med. 7, 1990-1999 PubMed
23. Zhang, Z., Zheng, W. and Hai, J. (2014) MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis. Med. Oncol. 31, 984 CrossRef PubMed
24. Zhang, J.G., Shi, Y., Hong, D.F., Song, M., Huang, D., Wang, C.Y. and Zhao, G. (2015) MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/beta-catenin pathway. Sci. Rep. 5, 8087 CrossRef PubMed
25. Prud'homme, G.J. and Glinka, Y. (2012) Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget 3, 921-939 PubMed
26. McKenna, G.J., Chen, Y., Smith, R.M., Meneghetti, A., Ong, C., McMaster, R., Scudamore, C.H. and Chung, S.W. (2002) A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am. J. Surg. 183, 588-594 CrossRef PubMed
27. Chiba, T., Miyagi, S., Saraya, A., Aoki, R., Seki, A., Morita, Y., Yonemitsu, Y., Yokosuka, O., Taniguchi, H., Nakauchi, H. and Iwama, A. (2008) The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res. 68, 7742-7749 CrossRef PubMed
28. Sandhu, R., Rivenbark, A.G. and Coleman, W.B. (2012) Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines. Int. J. Oncol. 41, 721-732 PubMed
29. Berge, M., Allanic, D., Bonnin, P., de Montrion, C., Richard, J., Suc, M., Boivin, J.F., Contreres, J.O., Lockhart, B.P., Pocard, M. etal. (2011) Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling. J. Hepatol. 55, 866-875 CrossRef PubMed
30. Chu, W., Song, X., Yang, X., Ma, L., Zhu, J., He, M., Wang, Z. and Wu, Y. (2014) Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma. PLoS One 9, e101931 CrossRef PubMed
31. Beck, B., Driessens, G., Goossens, S., Youssef, K.K., Kuchnio, A., Caauwe, A., Sotiropoulou, P.A., Loges, S., Lapouge, G., Candi, A. et al. (2011) A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478, 399-403 CrossRef PubMed
32. Glinka, Y., Mohammed, N., Subramaniam, V., Jothy, S. and Prud'homme, G.J. (2012) Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-kappaB activation and tumor sphere formation. Biochem. Biophys. Res. Commun. 425, 775-780 CrossRef PubMed
33. Hamerlik, P., Lathia, J.D., Rasmussen, R., Wu, Q., Bartkova, J., Lee, M., Moudry, P., Bartek, Jr, J., Fischer, W., Lukas, J. et al. (2012) Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. J. Exp. Med. 209, 507-520 CrossRef PubMed
34. Liang, W.C., Dennis, M.S., Stawicki, S., Chanthery, Y., Pan, Q., Chen, Y., Eigenbrot, C., Yin, J., Koch, A.W., Wu, X. et al. (2007) Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J. Mol. Biol. 366, 815-829 CrossRef PubMed
35. Teesalu, T., Sugahara, K.N., Kotamraju, V.R. and Ruoslahti, E. (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc. Natl. Acad. Sci. U.S.A. 106, 16157-16162 CrossRef PubMed
36. Roth, L., Agemy, L., Kotamraju, V.R., Braun, G., Teesalu, T., Sugahara, K.N., Hamzah, J. and Ruoslahti, E. (2011) Transtumoral targeting enabled by a novel neuropilin-binding peptide. Oncogene 31, 3754-3763 CrossRef PubMed
37. Qureshi, A.T., Monroe, W.T., Dasa, V., Gimble, J.M. and Hayes, D.J. (2013) miR-148b-nanoparticle conjugates for light mediated osteogenesis of human adipose stromal/stem cells. Biomaterials 34, 7799-7810 CrossRef PubMed